CooperVision produces hand sanitizer at manufacturing sites

Article

Initiative helps eye care and local communities address COVID-19

In response to the ongoing COVID-19 pandemic, CooperVision converted two of its manufacturing facilities into hand sanitizer production sites. One manufacturing location is in Hampshire, United Kingdom, the other is in Juana Diaz, Puerto Rico.

Benefits are two-fold: a portion of the sanitizer that is being produced stocks internal supplies for employee hygiene needs. This consistent, internal supply ensures commercial stocks are freed for consumer use elsewhere, according to the company. Additional reserves are being donated to community organizations and customers.

Related: CooperVision reveals virtual exhibit booth

Before conversion, the UK and Juana Diaz sites were manufacturing a range of contact lenses, including Biofinity and MyDay. Laboratory and operating procedure re-designs were issued in order to meet material handling retirements. The company was able to produce bottles of hand sanitizer in volume—safely, efficiently and in line with World Health Organization (WHO) guidelines—within 3 weeks.


Community recipients include areas of the National Health Service, schools, community facilities, care homes, and charities. In the US, the company has distributed complimentary bottles to customers as well.

Related: Allergan receives FDA complete response letter for wet AMD therapy

Recent Videos
Optometrists reflect on their residency experiences and provide advice to current residents.
EnVision Summit Co-chairs Sherrol Reynolds, OD, FAAO; Katie Rachon, OD, FAAO, Dipl ABO; Jessica Steen, OD, FAAO, Dipl ABO; and Cecelia Koetting, OD, FAAO, Dipl ABO; express excitement for the upcoming conference and why optometrists should attend.
Bonnie An Henderson, MD, the cofounder and program director of EnVision Summit
What was the biggest innovation in eye care in 2024?
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
Noreen Shaikh, OD, Magdalena Stec, OD, FAAO, and Brenda Bohnsack, MD, PhD, emphasize that collaboration and communication are key to proper diagnosis and treatment.
Cecilia Koetting, OD, FAAO, DipABO, cited data from a recent student that found that presbyopia treatment with 0.4% pilocarpine led to up to 86% of patients achieving 20/40 or better.
© 2024 MJH Life Sciences

All rights reserved.